← All companies

CYVN

Ceryvyn Therapeutics Limited

CYVNY OTC Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.03

+0.00 +3.85%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.00 – $3.41

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Nov 20, 2025 6-K Nov 12, 2025 6-K Oct 31, 2025 6-K Oct 30, 2025 6-K Oct 27, 2025 6-K Oct 10, 2025 6-K Oct 6, 2025 20-F Sep 15, 2025 6-K Sep 15, 2025 6-K Aug 29, 2025 6-K Aug 20, 2025 6-K Aug 19, 2025 6-K Aug 19, 2025 6-K Jun 2, 2025 6-K Apr 10, 2025 6-K Mar 31, 2025 6-K Mar 24, 2025 6-K Mar 3, 2025 6-K Feb 28, 2025 6-K Feb 26, 2025 6-K Feb 18, 2025 6-K Feb 7, 2025 6-K Feb 6, 2025 6-K Jan 28, 2025 6-K Jan 13, 2025 6-K Jan 8, 2025 6-K Jan 7, 2025 6-K Dec 19, 2024 6-K Nov 26, 2024 6-K Nov 25, 2024 6-K Nov 19, 2024 6-K Nov 15, 2024 6-K Nov 12, 2024 6-K Nov 4, 2024 6-K Nov 1, 2024 6-K Oct 28, 2024 6-K Oct 16, 2024 6-K Oct 16, 2024 6-K Oct 10, 2024 6-K Oct 8, 2024